Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men. The researchers say this calls for rethinking treatment guidelines based on a patient’s post-operative prostate-specific antigen (PSA) level. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago.
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago. The new introductions include the Somatom go.Sim and the Somatom go.Open Pro, both of which are pending U.S. Food and Drug Administration (FDA) 510(k) clearance and are not yet commercially available in the United States.
Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions. The speed, accuracy and noninvasiveness of medical imaging have also contributed to a sharp increase in the number of imaging procedures
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making the system available to clinicians in the United States.
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago. Visitors to the Philips booth will experience Philips IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity, improve efficiency and enable operational excellence in radiotherapy departments. The company will also highlight its Pinnacle Evolution treatment planning software, as well as its broad portfolio of connected oncology solutions designed to help health systems achieve the Quadruple Aim: an improved experience for patients and staff, better health outcomes and a lower cost of care.
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
People who live in rural America may deserve the same quality healthcare as anyone living in the U.S., but it is not ...
3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software allowing clinicians to 3-D print diagnostic patient-specific anatomic models.
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American Society for Radiation Oncology (ASTRO) 2019 annual meeting, Sept. 15-18 in Chicago. The company says its biology-guided radiotherapy (BgRT) platform is the first and only technology that unlocks the biological signature of each tumor to characterize its movement and direct highly conformal treatment to the tumor.
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming American Society for Radiation Oncology (ASTRO) congress, Sept. 15-19 in Chicago.
GE Healthcare announced the U.S. Food and Drug Administration’s (FDA) 510(k) clearance of Critical Care Suite, a collection of artificial intelligence (AI) algorithms embedded on a mobile X-ray device. Built in collaboration with UC San Francisco (UCSF) using GE Healthcare’s Edison platform, the AI algorithms help to reduce the turn-around time it can take for radiologists to review a suspected pneumothorax, a type of collapsed lung.
ViewRay Inc. announced that the company's MRIdian and MRIdian Linac magnetic resonance imaging (MRI)-guided radiation therapy systems will be featured at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-19 in Chicago. The meeting will feature a number of presentations highlighting the capabilities, clinical experience and patient outcomes with ViewRay's MRIdian and MRIdian Linac.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Richardson Healthcare, a Division of Richardson Electronics Ltd., announced it has received CE Mark approval for the ALTA750 X-ray computed tomography (CT) tube. The ALTA750 is a form, fit and function replacement for the Canon/Toshiba CXB-750D/4A.
RadCalc version 7.1 with the Monte Carlo 3-D module has been released for beta testing to members of the beta testing team. The Monte Carlo 3D module utilizes technology acquired from the McGill University inventors. This release of RadCalc 3Dmc is the second of three 3D Dose Volume second check quality assurance (QA) packages. The completion of the beta test is anticipated in four weeks. An announcement of the final release date will be provided when available for purchase.
Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex offers the latest CT injection technology from Bayer with a user-driven design, minimal required technologist training, and automation that drives individualized patient protocols and personalized imaging. The system also comes with flexible options for capital equipment through the TechCare program.
iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions in the global health and medical technology market, selected the ProFound AI platform as the winner of its “Best New Radiology Solution” award in the 2019 MedTech Breakthrough Awards program.
Accuray announced that it will showcase its motion-synchronization cancer treatment technologies at the upcoming 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 15 - 18 in Chicago. The company will provide multiple opportunities for attendees to explore its new innovations in patient-first cancer treatments, including booth presentations and demonstrations at its Innovation Pavilion and presentations at the Accuray Symposium.
Imaging Biometrics LLC (IB), in collaboration with the Medical College of Wisconsin (MCW), has received a $2.75 million, five-year grant award from the National Institutes of Health(NIH) - National Cancer Institute (NCI).
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...
Business-to-business communications leader Scranton Gillette Communications has named Diane Vojcanin as vice president, group publisher, healthcare group. Additionally, the company is announcing that Andreja Slapsys will serve as a healthcare group integrated media consultant.
September 16, 2019 